Aminoadamantane conjugates with carbazole derivatives as potential multitarget agents for the treatment of Alzheimer’s disease. Effect of the spacer structure
- Authors: Makhaeva G.F.1, Shevtsova E.F.1, Kovaleva N.V.1, Rudakova E.V.1, Neganova M.E.1, Dubova L.G.1, Shevtsov P.N.1, Aksinenko A.Y.1, Sokolov V.B.1, Bachurin S.O.1
-
Affiliations:
- Institute of Physiologically Active Compounds, Russian Academy of Sciences
- Issue: Vol 67, No 11 (2018)
- Pages: 2121-2126
- Section: Full Articles
- URL: https://journal-vniispk.ru/1066-5285/article/view/243199
- DOI: https://doi.org/10.1007/s11172-018-2338-6
- ID: 243199
Cite item
Abstract
The paper considers the influence of the structure of aminoadamantane–carbazole conjugates linked by five different spacers on their ability to inhibit acetylcholinesterase, butyrylcholinesterase (BChE), and carboxylesterase, the radical scavenging and mitoprotective activity, and tubulin polymerization. The nature of the spacer was found to be determinant for the appearance of anti-BChE and radical-scavenging activity. Aminoadamantane–carbazole conjugates linked by flexible spacers proved to be most effective in these assays. The influence of the conjugates on mitochondrial functions and tubulin polymerization largely depends on the structure of the carbazole moiety. A series of lead compounds promising for further study was identified as potential drugs for the treatment of neurodegenerative diseases, in particular, Alzheimer’s disease.
About the authors
G. F. Makhaeva
Institute of Physiologically Active Compounds, Russian Academy of Sciences
Author for correspondence.
Email: gmakh@ipac.ac.ru
Russian Federation, 1 Severny proezd, Chernogolovka, Moscow Region, 142432
E. F. Shevtsova
Institute of Physiologically Active Compounds, Russian Academy of Sciences
Email: gmakh@ipac.ac.ru
Russian Federation, 1 Severny proezd, Chernogolovka, Moscow Region, 142432
N. V. Kovaleva
Institute of Physiologically Active Compounds, Russian Academy of Sciences
Email: gmakh@ipac.ac.ru
Russian Federation, 1 Severny proezd, Chernogolovka, Moscow Region, 142432
E. V. Rudakova
Institute of Physiologically Active Compounds, Russian Academy of Sciences
Email: gmakh@ipac.ac.ru
Russian Federation, 1 Severny proezd, Chernogolovka, Moscow Region, 142432
M. E. Neganova
Institute of Physiologically Active Compounds, Russian Academy of Sciences
Email: gmakh@ipac.ac.ru
Russian Federation, 1 Severny proezd, Chernogolovka, Moscow Region, 142432
L. G. Dubova
Institute of Physiologically Active Compounds, Russian Academy of Sciences
Email: gmakh@ipac.ac.ru
Russian Federation, 1 Severny proezd, Chernogolovka, Moscow Region, 142432
P. N. Shevtsov
Institute of Physiologically Active Compounds, Russian Academy of Sciences
Email: gmakh@ipac.ac.ru
Russian Federation, 1 Severny proezd, Chernogolovka, Moscow Region, 142432
A. Yu. Aksinenko
Institute of Physiologically Active Compounds, Russian Academy of Sciences
Email: gmakh@ipac.ac.ru
Russian Federation, 1 Severny proezd, Chernogolovka, Moscow Region, 142432
V. B. Sokolov
Institute of Physiologically Active Compounds, Russian Academy of Sciences
Email: gmakh@ipac.ac.ru
Russian Federation, 1 Severny proezd, Chernogolovka, Moscow Region, 142432
S. O. Bachurin
Institute of Physiologically Active Compounds, Russian Academy of Sciences
Email: gmakh@ipac.ac.ru
Russian Federation, 1 Severny proezd, Chernogolovka, Moscow Region, 142432
Supplementary files
